Company / Working Capital
Tyra Biosciences, Inc. Working Capital History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$332.9M
FY2024
5-year range
$13.4M / $332.9M
FY2020-FY2024
Trend
+69.5%
vs FY2023
Sector context
#128 of 213
Health Care
What the data says
At $333M, Tyra Biosciences, Inc.'s working capital ranks #128 of 213 in the Health Care sector. Working Capital returned to growth in FY2024 after 2 years of decline, reaching $333M.
Based on SEC 10-K filings.
$333M in FY2024 with a 3-year CAGR of +3.5%.
Improved from $252M to $333M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- +3.5%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#128 of 213 in Health CareTop 60% of 213This company $332.9M Sector average $934.6M
▼
-64.4% below sector average
Key checks
Key Insights
- 3-year CAGR of +3.5%, indicating consistent growth.
- In FY2024, working capital increased 69.5% year-over-year.
- Ranks #128 out of 213 companies in the Health Care sector.
- Lowest working capital in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 6.83 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $332.9M | +69.5% |
| FY2023 | $196.3M | -22.0% |
| FY2022 | $251.6M | -16.3% |
| FY2021 | $300.4M | +2138.3% |
| FY2020 | $13.4M | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026